Economists are sounding alarms over the UK potentially losing £22bn in exports. This risk arises if former US President Donald Trump implements a proposed 20% tariff…
The prospect of a 20% tariff on UK imports to the US under Trump’s trade policies alarms economists. This move poses potential threats to key sectors,…
MMC Research has strategically expanded its operations to London to enhance its market reach.Alice Broomhall will spearhead the company’s initiatives from their new base.The London office…
Mace has announced significant promotions within its contracting division.Rob Lemming is appointed Managing Director of Public Sector & Life Sciences.Alister Grey assumes the role of Managing…
Medicine shortages have become more common in the UK in the past few years, according to research by the Nuffield Trust. Although global problems with supply…
Biotech giant Shire has said it would be willing to recommend an amended $64bn takeover bid from Takeda Pharmaceutical Co to shareholders, according to Reuters. The…
Irish biotechnology firm Elan Corp plc (NYSE:ELN) said it was launching a formal sale given expressions of interest it had received and would invite hostile suitor…
Swiss pharma major Novartis AG (VTX:NOVN) does not intend to pursue a takeover of US drugmaker Actavis Inc (NYSE:ACT), a company spokesperson told Reuters, refuting a…
UK drug maker GlaxoSmithKline Plc (LON:GSK) said today it had increased its stake in its Indian unit GlaxoSmithKline Consumer Healthcare Ltd to 72.5% from 43.2%, as…
British drugmaker GlaxoSmithKline Plc (LON:GSK) is seen to increase to some USD14.00 (EUR11.43) a share, or around USD2.8bn in total, from USD13.00 per share, its bid…
